You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Citation Tools

Article menu

Download PDFPDF

XML
HIV/AIDS
Protocol
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Costiniuk CT, Saneei Z, Routy J, et al
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
BMJ Open 2019;9:e024793. doi: 10.1136/bmjopen-2018-024793